Bisphosphonate-related osteonecrosis of the jaws

Kumar, Vandana; Pass, Barry; Guttenberg, Steven A.; Ludlow, John; Emery, Robert W.; Tyndall, Donald A.; Padilla, Ricordo J.
May 2007
Journal of the American Dental Association (JADA);May2007, Vol. 138 Issue 5, p602
Academic Journal
The article reports on several cases with contrasting treatment outcomes and morbidity in patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ). The authors demonstrate the usefulness of dental diagnostic imaging in the detection and management of BRONJ. The authors also discuss the danger associated with various BRONJ treatments.


Related Articles

  • Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Chiandussi, S.; Biasouo, M.; Dore, F.; Cavalli, F.; Cova, M. A.; Di Lenarda, R. // Dentomaxillofacial Radiology;Jul2006, Vol. 35 Issue 4, p236 

    Objectives: It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis...

  • Pamidronic acid/zoledronic acid.  // Reactions Weekly;2/25/2006, Issue 1090, p21 

    Presents several case reports on patients who developed jaw osteonecrosis after starting IV bisphosphonate therapy. Overview of the various diseases of the patients; Background on the treatments received by the patients; Effect of the discontinuation of the bisphosphonate therapy of patients.

  • Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. Frieder Bauss; Thomas Pfister; Socrates Papapoulos // Journal of Bone & Mineral Metabolism;Jul2008, Vol. 26 Issue 4, p406 

    Abstract  Intravenous bisphosphonates may be involved in the development of osteonecrosis of the jaw (ONJ). However, a mechanistic causality has not been demonstrated. To evaluate whether there is higher drug uptake by the jaw versus other bones that might be involved in ONJ pathogenesis,...

  • Osteonecrosis of the Jaw – Do Bisphosphonates Pose a Risk? Bilezikian, John P. // New England Journal of Medicine;11/30/2006, Vol. 355 Issue 22, p2278 

    The article presents the author's views regarding the use of bisphosphonates therapy for patients with osteonecrosis of the jaw. He says that although more research is still needed to clarify the risks of bisphosphonates therapy, its benefits clearly outweigh whatever small risk might be...

  • Bisphosphonates, Phossy Jaw, and Bisphosphonate-Related Osteonecrosis of the Jaw. LEWIS, DAVID M. // Oklahoma Dental Association Journal;Jul2011, Vol. 102 Issue 5, p36 

    The article offers information on bisphosphonates, phossy jaw and bisphosphonate-related osteonecrosis of the jaw (BRONJ). It states that bisphosphonates were first synthesized in 1868 and became valuable in the textile, fertilizer and oil industries due to their ability to inhibit calcium...

  • Evolution and Etiopathogenesis of Bisphosphonates Induced Osteonecrosis of the Jaw. Kumar, Vijay; Kant Sinha, Raman // North American Journal of Medical Sciences;Apr2013, Vol. 5 Issue 4, p260 

    Bisphosphonates (BPs) is widely used as the first line of treatment choice for osteoporosis, Paget's disease of bone, bone cancer metastasis and hypercalcemia of malignancy. BPs induced osteonecrosis of the jaw (ONJ) is a relatively rare but severe clinical condition cited in English literature...

  • Anatomic Factors related to bisphosphonate Osteonecrosis of the Jaws: a Portuguese retrospective study. ÁLVARES FURTADO, Ivo; CALDAS, Cecília FRANCO; LANÇA, Fernanda; SALVADO E. SILVA, Francisco // Acta Medica Portuguesa;Mar/Apr2012, Vol. 25 Issue 2, p106 

    Aims: The objectives of this study of bisphosphonate-related osteonecrosis of the jaws (BRONJ) were to determine local distribution, possible anatomically associated or determinant factors and other bone involvement of the disease, contributing with this new data towards the establishment of its...

  • Osteonecrosis of the jaw and bisphosphonate use: How big a risk? Levitan, Dave // Endocrine Today;3/10/2008, Vol. 6 Issue 4, p1 

    The article focuses on the relationship between osteonecrosis of the jaw (ONJ) and bisphosphonate use. ONJ is described as the presence of exposed bone in the maxillofacial region that does not heal within eight weeks after being seen by a primary care provider. Pain from ONJ can be unremitting...

  • Bisphosphonate-associated osteonecrosis of the jaw. Basu, Neil; Reid, David M. // Menopause International;Jun2007, Vol. 13 Issue 2, p56 

    The term 'osteonecrosis of the jaw' is typically used to describe the exposure of bone within the oral cavity. These lesions are often painful and can result in pathological fracture and disfigurement in severe cases. Infection and dental extractions commonly precede presentation, although...


Read the Article


Sign out of this library

Other Topics